According to latest Research, the global market for Clinical Next Generation Sequencing (NGS) should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Clinical Next Generation Sequencing (NGS) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Clinical Next Generation Sequencing (NGS) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Sequencing by Synthesis (SBS) segment holds a share about % in 2023 and will reach % in 2029; while in terms of application, Diagnostics has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Clinical Next Generation Sequencing (NGS) include Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, Bio-Rad and Congenica, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Clinical Next Generation Sequencing (NGS). Report Highlights:

(1) Global Clinical Next Generation Sequencing (NGS) market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Clinical Next Generation Sequencing (NGS) market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Clinical Next Generation Sequencing (NGS) market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Clinical Next Generation Sequencing (NGS) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Clinical Next Generation Sequencing (NGS) segment by type and by application and regional segment by type and by application.

(6) Clinical Next Generation Sequencing (NGS) industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Sequencing by Synthesis (SBS)

Nanopore Sequencing

Single-Molecule Real-Time (SMRT) Sequencing

Others

Market segment by application, can be divided into

Diagnostics

Drug Discovery & Designing

Medical Research

Others

Market segment by players, this report covers

Agilent Technologies

Illumina

Thermo Fisher Scientific

Eurofins Scientific

BGI Group

Qiagen

Roche Diagnostics

Bio-Rad

Congenica

Theragen Etex

PerkinElmer

Partek

Oxford Nanopore Technologies

Pacific Biosciences of California

Golden Helix

BioDatomics

PierianDx

DNAStar

1 Market Overview

1.1 Product Overview and Scope of Clinical Next Generation Sequencing (NGS)

1.2 Global Clinical Next Generation Sequencing (NGS) Market Size and Forecast

1.3 China Clinical Next Generation Sequencing (NGS) Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Clinical Next Generation Sequencing (NGS) Share in Global Market, 2019-2030

1.4.2 Clinical Next Generation Sequencing (NGS) Market Size: China VS Global, 2019-2030

1.5 Clinical Next Generation Sequencing (NGS) Market Dynamics

1.5.1 Clinical Next Generation Sequencing (NGS) Market Drivers

1.5.2 Clinical Next Generation Sequencing (NGS) Market Restraints

1.5.3 Clinical Next Generation Sequencing (NGS) Industry Trends

1.5.4 Clinical Next Generation Sequencing (NGS) Industry Policy

2 Global Competitive Situation by Company

2.1 Global Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024)

2.2 Global Clinical Next Generation Sequencing (NGS) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Clinical Next Generation Sequencing (NGS) Concentration Ratio

2.4 Global Clinical Next Generation Sequencing (NGS) Mergers & Acquisitions, Expansion Plans

2.5 Global Clinical Next Generation Sequencing (NGS) Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024)

3.2 China Clinical Next Generation Sequencing (NGS) Clinical Next Generation Sequencing (NGS) Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Clinical Next Generation Sequencing (NGS), Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Clinical Next Generation Sequencing (NGS) Industry Chain

4.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis

4.3 Clinical Next Generation Sequencing (NGS) Midstream Analysis

4.4 Clinical Next Generation Sequencing (NGS) Downstream Analysis

5 Sights by Type

5.1 Clinical Next Generation Sequencing (NGS) Classification

5.1.1 Sequencing by Synthesis (SBS)

5.1.2 Nanopore Sequencing

5.1.3 Single-Molecule Real-Time (SMRT) Sequencing

5.1.4 Others

5.2 By Type, Global Clinical Next Generation Sequencing (NGS) Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030

6 Sights by Application

6.1 Clinical Next Generation Sequencing (NGS) Segment by Application

6.1.1 Diagnostics

6.1.2 Drug Discovery & Designing

6.1.3 Medical Research

6.1.4 Others

6.2 By Application, Global Clinical Next Generation Sequencing (NGS) Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Clinical Next Generation Sequencing (NGS) Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

7.3 North America

7.3.1 North America Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Clinical Next Generation Sequencing (NGS) Market Size Market Share

7.4 Europe

7.4.1 Europe Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size Market Share

7.6 South America

7.6.1 South America Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Clinical Next Generation Sequencing (NGS) Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Clinical Next Generation Sequencing (NGS) Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.3.2 By Company, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.3.4 By Application, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.4 Europe

8.4.1 Europe Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.4.2 By Company, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.4.4 By Application, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.5 China

8.5.1 China Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.5.2 By Company, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.5.3 By Type, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.5.4 By Application, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.6 Japan

8.6.1 Japan Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.6.2 By Company, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.6.4 By Application, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.7 South Korea

8.7.1 South Korea Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.7.2 By Company, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.7.4 By Application, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.8.4 By Application, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.9 India

8.9.1 India Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.9.2 By Company, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.9.3 By Type, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.9.4 By Application, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

8.10.4 By Application, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2024 VS 2030

9 Global Manufacturers Profile

9.1 Agilent Technologies

9.1.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position

9.1.2 Agilent Technologies Company Profile and Main Business

9.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.1.5 Agilent Technologies Recent Developments

9.2 Illumina

9.2.1 Illumina Company Information, Head Office, Market Area and Industry Position

9.2.2 Illumina Company Profile and Main Business

9.2.3 Illumina Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.2.5 Illumina Recent Developments

9.3 Thermo Fisher Scientific

9.3.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

9.3.2 Thermo Fisher Scientific Company Profile and Main Business

9.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.3.5 Thermo Fisher Scientific Recent Developments

9.4 Eurofins Scientific

9.4.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position

9.4.2 Eurofins Scientific Company Profile and Main Business

9.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.4.5 Eurofins Scientific Recent Developments

9.5 BGI Group

9.5.1 BGI Group Company Information, Head Office, Market Area and Industry Position

9.5.2 BGI Group Company Profile and Main Business

9.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.5.5 BGI Group Recent Developments

9.6 Qiagen

9.6.1 Qiagen Company Information, Head Office, Market Area and Industry Position

9.6.2 Qiagen Company Profile and Main Business

9.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.6.5 Qiagen Recent Developments

9.7 Roche Diagnostics

9.7.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

9.7.2 Roche Diagnostics Company Profile and Main Business

9.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.7.5 Roche Diagnostics Recent Developments

9.8 Bio-Rad

9.8.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position

9.8.2 Bio-Rad Company Profile and Main Business

9.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.8.5 Bio-Rad Recent Developments

9.9 Congenica

9.9.1 Congenica Company Information, Head Office, Market Area and Industry Position

9.9.2 Congenica Company Profile and Main Business

9.9.3 Congenica Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.9.5 Congenica Recent Developments

9.10 Theragen Etex

9.10.1 Theragen Etex Company Information, Head Office, Market Area and Industry Position

9.10.2 Theragen Etex Company Profile and Main Business

9.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.10.5 Theragen Etex Recent Developments

9.11 PerkinElmer

9.11.1 PerkinElmer Company Information, Head Office, Market Area and Industry Position

9.11.2 PerkinElmer Company Profile and Main Business

9.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.11.5 PerkinElmer Recent Developments

9.12 Partek

9.12.1 Partek Company Information, Head Office, Market Area and Industry Position

9.12.2 Partek Company Profile and Main Business

9.12.3 Partek Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.12.5 Partek Recent Developments

9.13 Oxford Nanopore Technologies

9.13.1 Oxford Nanopore Technologies Company Information, Head Office, Market Area and Industry Position

9.13.2 Oxford Nanopore Technologies Company Profile and Main Business

9.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.13.5 Oxford Nanopore Technologies Recent Developments

9.14 Pacific Biosciences of California

9.14.1 Pacific Biosciences of California Company Information, Head Office, Market Area and Industry Position

9.14.2 Pacific Biosciences of California Company Profile and Main Business

9.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.14.5 Pacific Biosciences of California Recent Developments

9.15 Golden Helix

9.15.1 Golden Helix Company Information, Head Office, Market Area and Industry Position

9.15.2 Golden Helix Company Profile and Main Business

9.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.15.5 Golden Helix Recent Developments

9.16 BioDatomics

9.16.1 BioDatomics Company Information, Head Office, Market Area and Industry Position

9.16.2 BioDatomics Company Profile and Main Business

9.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.16.5 BioDatomics Recent Developments

9.17 PierianDx

9.17.1 PierianDx Company Information, Head Office, Market Area and Industry Position

9.17.2 PierianDx Company Profile and Main Business

9.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.17.5 PierianDx Recent Developments

9.18 DNAStar

9.18.1 DNAStar Company Information, Head Office, Market Area and Industry Position

9.18.2 DNAStar Company Profile and Main Business

9.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

9.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

9.18.5 DNAStar Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Clinical Next Generation Sequencing (NGS) Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Clinical Next Generation Sequencing (NGS) Market Restraints

Table 3. Clinical Next Generation Sequencing (NGS) Market Trends

Table 4. Clinical Next Generation Sequencing (NGS) Industry Policy

Table 5. Global Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Company (2019-2024)

Table 7. Global Clinical Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Clinical Next Generation Sequencing (NGS) Mergers & Acquisitions, Expansion Plans

Table 9. Global Clinical Next Generation Sequencing (NGS) Manufacturers Product Type

Table 10. China Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024) & (US$ million)

Table 11. China Clinical Next Generation Sequencing (NGS) Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Clinical Next Generation Sequencing (NGS) Upstream (Raw Materials)

Table 13. Global Clinical Next Generation Sequencing (NGS) Typical Customers

Table 14. Clinical Next Generation Sequencing (NGS) Typical Distributors

Table 15. By Type, Global Clinical Next Generation Sequencing (NGS) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Clinical Next Generation Sequencing (NGS) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Clinical Next Generation Sequencing (NGS) Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Clinical Next Generation Sequencing (NGS) Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Table 22. Agilent Technologies Company Information, Head Office, Market Area and Industry Position

Table 23. Agilent Technologies Company Profile and Main Business

Table 24. Agilent Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 25. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 26. Agilent Technologies Recent Developments

Table 27. Illumina Company Information, Head Office, Market Area and Industry Position

Table 28. Illumina Company Profile and Main Business

Table 29. Illumina Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 30. Illumina Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 31. Illumina Recent Developments

Table 32. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 33. Thermo Fisher Scientific Company Profile and Main Business

Table 34. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 35. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 36. Thermo Fisher Scientific Recent Developments

Table 37. Eurofins Scientific Company Information, Head Office, Market Area and Industry Position

Table 38. Eurofins Scientific Company Profile and Main Business

Table 39. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 40. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 41. Eurofins Scientific Recent Developments

Table 42. BGI Group Company Information, Head Office, Market Area and Industry Position

Table 43. BGI Group Company Profile and Main Business

Table 44. BGI Group Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 45. BGI Group Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 46. BGI Group Recent Developments

Table 47. Qiagen Company Information, Head Office, Market Area and Industry Position

Table 48. Qiagen Company Profile and Main Business

Table 49. Qiagen Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 50. Qiagen Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 51. Qiagen Recent Developments

Table 52. Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 53. Roche Diagnostics Company Profile and Main Business

Table 54. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 55. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 56. Roche Diagnostics Recent Developments

Table 57. Bio-Rad Company Information, Head Office, Market Area and Industry Position

Table 58. Bio-Rad Company Profile and Main Business

Table 59. Bio-Rad Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 60. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 61. Bio-Rad Recent Developments

Table 62. Congenica Company Information, Head Office, Market Area and Industry Position

Table 63. Congenica Company Profile and Main Business

Table 64. Congenica Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 65. Congenica Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 66. Congenica Recent Developments

Table 67. Theragen Etex Company Information, Head Office, Market Area and Industry Position

Table 68. Theragen Etex Company Profile and Main Business

Table 69. Theragen Etex Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 70. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 71. Theragen Etex Recent Developments

Table 72. PerkinElmer Company Information, Head Office, Market Area and Industry Position

Table 73. PerkinElmer Company Profile and Main Business

Table 74. PerkinElmer Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 75. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 76. PerkinElmer Recent Developments

Table 77. Partek Company Information, Head Office, Market Area and Industry Position

Table 78. Partek Company Profile and Main Business

Table 79. Partek Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 80. Partek Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 81. Partek Recent Developments

Table 82. Oxford Nanopore Technologies Company Information, Head Office, Market Area and Industry Position

Table 83. Oxford Nanopore Technologies Company Profile and Main Business

Table 84. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 85. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 86. Oxford Nanopore Technologies Recent Developments

Table 87. Pacific Biosciences of California Company Information, Head Office, Market Area and Industry Position

Table 88. Pacific Biosciences of California Company Profile and Main Business

Table 89. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 90. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 91. Pacific Biosciences of California Recent Developments

Table 92. Golden Helix Company Information, Head Office, Market Area and Industry Position

Table 93. Golden Helix Company Profile and Main Business

Table 94. Golden Helix Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 95. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 96. Golden Helix Recent Developments

Table 97. BioDatomics Company Information, Head Office, Market Area and Industry Position

Table 98. BioDatomics Company Profile and Main Business

Table 99. BioDatomics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 100. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 101. BioDatomics Recent Developments

Table 102. PierianDx Company Information, Head Office, Market Area and Industry Position

Table 103. PierianDx Company Profile and Main Business

Table 104. PierianDx Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 105. PierianDx Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 106. PierianDx Recent Developments

Table 107. DNAStar Company Information, Head Office, Market Area and Industry Position

Table 108. DNAStar Company Profile and Main Business

Table 109. DNAStar Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 110. DNAStar Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 111. DNAStar Recent Developments

List of Figure

Figure 1. Clinical Next Generation Sequencing (NGS) Picture

Figure 2. Global Clinical Next Generation Sequencing (NGS) Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Clinical Next Generation Sequencing (NGS) Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Clinical Next Generation Sequencing (NGS) Market Share of Global

Figure 5. Global Clinical Next Generation Sequencing (NGS) Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 6. Global Clinical Next Generation Sequencing (NGS) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Clinical Next Generation Sequencing (NGS) Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 8. China Clinical Next Generation Sequencing (NGS) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Clinical Next Generation Sequencing (NGS) Industry Chain

Figure 10. Sequencing by Synthesis (SBS)

Figure 11. Nanopore Sequencing

Figure 12. Single-Molecule Real-Time (SMRT) Sequencing

Figure 13. Others

Figure 14. By Type, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Figure 15. By Type, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Figure 16. Diagnostics

Figure 17. Drug Discovery & Designing

Figure 18. Medical Research

Figure 19. Others

Figure 20. By Application, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Figure 21. By Application, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Figure 22. By Region, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Figure 23. North America Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 24. By Country, North America Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 25. Europe Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 26. By Country, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 27. Asia Pacific Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 28. By Country/Region, Asia Pacific Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 29. South America Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 30. By Country, South America Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 31. Middle East & Africa Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 32. U.S. Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 33. By Company, U.S. Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 34. By Type, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 35. By Application, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 36. Europe Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 37. By Company, Europe Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 38. By Type, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 39. By Application, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 40. China Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 41. By Company, China Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 42. By Type, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 43. By Application, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 44. Japan Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 45. By Company, Japan Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 46. By Type, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 47. By Application, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 48. South Korea Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 49. By Company, South Korea Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 50. By Type, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 51. By Application, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 52. Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 53. By Company, Southeast Asia Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 54. By Type, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 55. By Application, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 56. India Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 57. By Company, India Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 58. By Type, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 59. By Application, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 60. Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 61. By Company, Middle East & Asia Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 62. By Type, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 63. By Application, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)